Prof. Dr. MÜMİN KAZIM YAZICI

Yayın Ağı

Makaleler 31

1. A follow-up study of metabolic syndrome in schizophrenia

Yoca G., ANIL YAĞCIOĞLU A. E., Eni N., KARAHAN S., TÜRKOĞLU İ., Akal Yıldız E., et al.

European Archives Of Psychiatry And Clinical Neuroscience , cilt.270, ss.611-618, 2020 (SCI-Expanded, Scopus)

2. Oral Naltrexone in the Treatment of Chronic Psychogenic Pruritus: A Case Report

Aytulun A., Ozcelik-Eroglu E., YILDIZ M. İ., Yalici-Armagan B., Yazici M. K.

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , cilt.30, sa.2, ss.199-201, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. A comparative study of detection of myocarditis induced by clozapine: With and without cardiac monitoring

ANIL YAĞCIOĞLU A. E., ERTUĞRUL A., KARAKAŞLI A. A., Ağaoğlu E., AK S., KARAHAN S., et al.

Psychiatry Research , cilt.279, ss.90-97, 2019 (SCI-Expanded, SSCI, Scopus)

4. Examination of formal thought disorder and its clinical correlates with the Turkish Version of the Thought and Language Disorder Scale (TALD-TR) in schizophrenia

MUTLU E., YAZICI M. K., BARIŞKIN E., ERTUĞRUL A., GÜREL Ş. C., Gürkan Ş., et al.

Comprehensive Psychiatry , cilt.93, ss.7-13, 2019 (SCI-Expanded, SSCI, Scopus)

5. Şizofreninin Nörobiyolojisi

ÖZÇELİK EROĞLU E., YAZICI M. K.

Türkiye Psikiyatri Derneği Sürekli Eğitim/Sürekli Mesleki Gelişim Dergisi , cilt.9, sa.1, ss.27-38, 2019 (Hakemli Dergi)

6. L-Arginine Add-On Treatment for Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

KOÇYİĞİT Y., Yoca G., KARAHAN S., AYHAN Y., YAZICI M. K.

TURK PSIKIYATRI DERGISI , cilt.29, sa.3, 2018 (SSCI, Scopus, TRDizin)

7. Relation of the Allelic Variants of Multidrug Resistance Gene to Agranulocytosis Associated With Clozapine

YAGCIOGLU A. E., Yoca G., AYHAN Y., KARACA R. O., Cevik L., MÜDERRİSOĞLU A., et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.36, sa.3, ss.257-261, 2016 (SCI-Expanded, Scopus)

8. Prediction of Response to Antipsychotic Drugs in Schizophrenia Patients within the Early Phase of Treatment

Yildiz M. K., YAZICI M. K., YAGCIOGLU A. E. A., KARAHAN S., SEVIK A. E., GURSES N.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.25, sa.4, ss.390-398, 2015 (SCI-Expanded, Scopus, TRDizin)

9. Serotonin syndrome with a combination of aripiprazole and fluoxetine: A case report

BOSTANKOLU G., AYHAN Y., Cuhadaroglu F., YAZICI M. K.

Therapeutic Advances in Psychopharmacology , cilt.5, sa.2, ss.138-140, 2015 (SCI-Expanded, Scopus)

10. Prediction of response to antipsychotic drugs in schizophrenia patients within the early phase of treatment

YILDIZ M., YAZICI M. K., ANIL YAĞCIOĞLU A. E., KARAHAN S., Şevik A. E., GÜRSES N.

Bulletin of Clinical Psychopharmacology , cilt.25, ss.390-398, 2015 (SCI-Expanded)

11. Effect of clozapine on white matter integrity in patients with schizophrenia: A diffusion tensor imaging study

OZCELIK-EROGLU E., ERTUĞRUL A., OGUZ K. K., Has A. C., KARAHAN S., YAZICI M. K.

PSYCHIATRY RESEARCH-NEUROIMAGING , cilt.223, sa.3, ss.226-235, 2014 (SCI-Expanded, Scopus)

12. Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment

Vayisoglu S., Yagcioglu A. E., Yagcioglu S., KARAHAN S., Karci O., GÜREL Ş. C., et al.

SCHIZOPHRENIA RESEARCH , cilt.143, sa.1, ss.207-214, 2013 (SCI-Expanded, SSCI, Scopus)

13. Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment

VAYISOĞLU S., ANIL YAĞCIOĞLU A. E., YAĞCIOĞLU S., KARAHAN S., KARCI O., GÜREL Ş. C., et al.

Schizophrneia Research , cilt.143, ss.207-214, 2013 (SCI-Expanded)

14. Agranulocytosis Related to Clozapine in Monozygotic Twins and Association With Allelic Variants of Multidrug Resistance Gene MDR1

ANIL YAĞCIOĞLU A. E., İLHAN ÇETİN B., GÖKTAŞ M., BABAOĞLU M. Ö., Uz E., YAZICI M. K.

Journal Of Clinical Psychopharmacology , cilt.31, ss.247-249, 2011 (SCI-Expanded, Scopus)

15. The Schedule for Schizotypal Personalities: reliability study of Turkish version

ÖZER S., DEMİR B., YAZICI M. K.

ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , cilt.11, sa.4, ss.313-320, 2010 (SCI-Expanded, Scopus, TRDizin)

16. Validity and Reliability of the Revised Physical Anhedonia Scale-Turkish Version in University Students

Baskak B., Saka M. C., Gonullu I., Artar M., Kizil E. T. O., YAZICI M. S., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.46, ss.43-48, 2009 (SCI-Expanded, Scopus, TRDizin)

17. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: Effects on cognition

AKDEDE B. B. K., YAGCIOGLU A. E. A., ALPTEKIN K., TURGUT T. I., TUMUKLU M., Yazici M. K., et al.

JOURNAL OF CLINICAL PSYCHIATRY , cilt.67, sa.12, ss.1912-1919, 2006 (SCI-Expanded, SSCI, Scopus)

18. A double blind study of combination of clozapine with risperidone in patients with schizophrenia effects on cognition

AKDEDE B. B., ANIL YAĞCIOĞLU A. E., ALPTEKİN K., TURGUT T. İ., TÜMÜKLÜ M., YAZICI M. K., et al.

Journal of Clinical Psychiatry , cilt.67, ss.1912-1919, 2006 (SCI-Expanded, SSCI, Scopus)

19. Anaesthetists and surgeons estimation of preoperative anxiety by patients submitted for elective surgery in a university hospital

FEKRAT F., ŞAHİN A., YAZICI M. K., AYPAR Ü.

Eur J Anaesthesiol , 2006 (Hakemli Dergi)

20. Disability in schizophrenia: Clinical correlates and prediction over 1-year follow-up

Alptekin K., Erkoc S., Gogus A., Kultur S., Mete L., Ucok A., et al.

PSYCHIATRY RESEARCH , cilt.135, sa.2, ss.103-111, 2005 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

21. Creutzfeldt Jakob disease A case that initiated with psychiatricsymptoms

KURNE A., ERTUĞRUL A., ANIL YAĞCIOĞLU A. E., YAZICI M. K., DEMİRCİ E., KANSU T.

TURK PSIKIYATRI DERGISI , cilt.16, ss.55-59, 2005 (SCI-Expanded, Scopus, TRDizin)

22. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety

YAGCIOGLU A. E., AKDEDE B., TURGUT T., TUMUKLU M., YAZICI M., ALPTEKIN K., et al.

JOURNAL OF CLINICAL PSYCHIATRY , cilt.66, sa.1, ss.63-72, 2005 (SCI-Expanded, SSCI, Scopus)

23. A double blind controlled study of adjunctive treatment with risperidonein schizophrenic patients partially responsive to clozapine Efficacyand safety

ANIL YAĞCIOĞLU A. E., AKDEDE B. B., TURGUT T. İ., TÜMÜKLÜ M., YAZICI M. K., ERTUĞRUL A., et al.

JOURNAL OF CLINICAL PSYCHIATRY , cilt.66, ss.63-72, 2005 (SCI-Expanded, SSCI, Scopus)

24. A Double Blind Placebo Controlled Cross Over Trial of Adjunctive Donepezil for Cognitive Impairment in Schizophrenia

TUĞAL Ö., YAZICI M. K., ANIL YAĞCIOĞLU A. E., GÖĞÜŞ A.

The International Journal of Neuropsychopharmacology , cilt.7, ss.117-123, 2004 (SCI-Expanded)

25. Re Examination of the Characteristics of the Deficit Schizophrenia Patients

TİRYAKİ A., YAZICI M. K., ANIL A. E., KABAKÇI E., KARAAĞAOĞLU A. E., GÖĞÜŞ A.

European Archives of Psychiatry and Clinical Neuroscience , cilt.253, ss.221-227, 2003 (SCI-Expanded, Scopus)

26. Reexamination of the characteristics of the deficit schizophrenia patients

TIRYAKI A., Yazici M. K., ANIL A. E., KABAKCI E., KARAAGAOGLU E., GOGUS A.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE , cilt.253, sa.5, ss.221-227, 2003 (SCI-Expanded, Scopus)

27. Neurological soft signs in schizophrenic patients and their nonpsychotic siblings

Yazici A., Demir B., Yazici K., Gogus A.

SCHIZOPHRENIA RESEARCH , cilt.58, ss.241-246, 2002 (SCI-Expanded, SSCI, Scopus)

28. Mixed anxiety-depressive disorder and major depressive disorder: comparison of the severity of illness and biological variables

Kara S., Yazici K., Gulec C., Unsal I.

PSYCHIATRY RESEARCH , cilt.94, sa.1, ss.59-66, 2000 (SCI-Expanded, SSCI, Scopus)

29. Yeni Kuşak Antidepresanlar

ANIL A. E., YAZICI M. K.

Hacettepe Tıp Dergisi , cilt.31, ss.353-361, 2000 (Hakemsiz Dergi)

30. Ketoacidosis as a side effect of clozapine A case report

KOSTAKOĞLU A. E., YAZICI M. K., ERBAŞ A. T., GÜVENER DEMİRAĞ H. N.

ACTA PSYCHİATRİCA SCANDİNAVİCA , cilt.93, ss.217-218, 1998 (SCI-Expanded, SSCI, Scopus)

31. The effect of clozapine on glucose metabolism

Yazici K., ERBAS T., YAZICI A. R.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.106, sa.6, ss.475-477, 1998 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 11

1. FENILKETONÜRI TANISI OLAN BIR HASTADA YAYGIN GELIŞIMSEL BOZUKLUK VE KATATONI

KARAÇAM M., ÖZDEN H., ÖZÇELİK EROĞLU E., YILDIZ M. İ., YAZICI M. K.

55. Ulusal Psikiyatri Kongresi, Türkiye, 23 - 27 Ekim 2019, (Özet Bildiri)

2. The effect of electroconvulsive therapy on autobiographical memory inpatients with a major depressive episode

DEMİRSÖZ T., abullayeva l., GÜREL Ş. C., AK S., KARAHAN S., AYHAN Y., et al.

11. Uluslararası Psikofarmakoloji Kongresi, 18 - 21 Nisan 2019, (Özet Bildiri)

3. THE ROLE OF THE CLINICAL PHARMACIST IN DRUG EDUCATION FOR INCREASING COMPLIANCE WITH DRUG THERAPY IN THE PERIOD OF DISCHARGE WITH THE DIAGNOSIS OF SCHIZOPHRENIA SPECTRUM DISORDERS

YALÇIN N., ÇELİKER A., GÜREL Ş. C., AK S., YAZICI M. K.

6th Schizophrenia International Research Society Conference, İtalya, 4 - 08 Nisan 2018, cilt.44, ss.345, (Özet Bildiri)

4. Evaluating the effects of body composition on metabolic profile in patients with schizophrenia

TÜRKOĞLU İ., YILDIZ E., MERCANLIGİL S. M., Yoca G., YAZICI M. K.

39th ESPEN Congress, The Hague, Hollanda, 9 - 12 Eylül 2017, cilt.36, ss.147, (Özet Bildiri)

5. Evaluating the effects of dietary fatty acid and antioxidant vitamin intake on metabolic profile in patients with schizophrenia

TÜRKOĞLU İ., YILDIZ E., MERCANLIGİL S. M., Yoca G., YAZICI M. K.

39th ESPEN Congress, The Hague, Hollanda, 9 - 12 Eylül 2017, cilt.36, ss.165, (Özet Bildiri)

6. Evaluating the effects of physical activity status on metabolic profile in patients with schizophrenia

TÜRKOĞLU İ., YILDIZ E., MERCANLIGİL S. M., Yoca G., YAZICI M. K.

39th ESPEN Congress, The Hague, Hollanda, 9 - 12 Eylül 2017, cilt.36, ss.45, (Özet Bildiri)

7. Schizophrenia and Metabolic Syndorme Follow Up Study

Yoca G., YAZICI M. K., ANIL YAĞCIOĞLU A. E., Eni N., KARAHAN S., TÜRKOĞLU İ., et al.

5th Biennial SIRS Conference, 2 - 06 Nisan 2016

8. The prevalence of metabolic syndrome in schizophrenic patients: a preliminary report

Yazici M., ANIL YAĞCIOĞLU A. E., Ertugrul A., Eni N., Karaagaoglu E., Tokgozoglu S.

18th ECNP Congress 2005, Amsterdam, Hollanda, 22 - 26 Ekim 2005, cilt.15, (Özet Bildiri)

9. Double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety

Yagciolglu A., Akdede B., Turgut T., Tumuklu M., Yazici M., Alptekin K., et al.

24th CINP Congress, Paris, Fransa, 20 - 24 Haziran 2004, cilt.7, (Özet Bildiri)

10. The occurence of obsessive compulsive symptoms in clozapine treated schizophrenic patients: Relationship with other clinical features

ANIL YAĞCIOĞLU A. E., Ertugrul A., Eni N., Yazici M.

16th Congress of the European-College-of-Neuropsychopharmacology, PRAGUE, Çek Cumhuriyeti, 20 - 24 Eylül 2003, cilt.13, (Özet Bildiri)

11. A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for the cognitive impairment of schizophrenia

Tugal O., Yazici K.

16th Congress of the European-College-of-Neuropsychopharmacology, PRAGUE, Çek Cumhuriyeti, 20 - 24 Eylül 2003, cilt.13, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

686

H-İndeks (WoS)

Atıf (Scopus)

815

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (Diğer Toplam)

Proje

Açık Erişim